Patent · US Expired

Method of detecting elastase IV

US5738991A · kind A · utility

3Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 1995
Grant dateApr 14, 1998
Priority date
Expiry dateDec 6, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides nucleotide and amino acid sequences that identify and encode a human homolog of rat elastase IV (HEIV) expressed in pancreas tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode HEIV, hybridization probes or oligonucleotides for the detection of HEIV-encoding nucleotide sequences, and a diagnostic test based on HEIV-encoding nucleic acid molecules. The present invention further provides for genetically engineered host cells for the expression of HEIV, biologically active HEIV, antibodies capable for binding specifically to HEIV, and treatment methods comprising administration of compounds, such antibodies or inhibitors, capable of binding HEIV to alter its activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.